Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter]

Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter]

Bibliographic Details
Main Authors: Cannon, C.P (Author), Charbonnel, B. (Author), Cherney, D.Z.I (Author), Cosentino, F. (Author), Dagogo-Jack, S. (Author), Frederich, R. (Author), Maldonado, M. (Author), McGuire, D.K (Author), on behalf of the VERTIS CV Investigators (Author), Pong, A. (Author), Pratley, R. (Author), Shih, W.J (Author)
Format: Article
Language:English
Published: Springer Science and Business Media Deutschland GmbH 2022
Subjects:
Body weight
Chronic kidney disease
Ertugliflozin
Estimated glomerular filtration rate
Kidney outcomes
Sodium–glucose cotransporter 2 inhibitor
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items